secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apellis Pharmaceuticals, Inc. (APLS)
CIK:        0001492422
Form:       8-K
Filed at:   2021-07-08T23:59:59+00:00
Accession:  0001193125-21-210295
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Apellis exchanges $198.6M in convertible notes for common stock; closing July 23
--------------------------------------------------------------------------------

- Agreed to exchange ~$198.6M principal of 3.500% Convertible Senior Notes due 2026 for shares.
- Fixed issuance of 4,530,431 shares (22.8065 per $1,000 principal) plus additional variable shares tied to VWAP.
- Exchange expected to close July 23, 2021, subject to customary conditions.
- Shares issued in private placement to QIBs and institutional accredited investors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1492422/000119312521210295/0001193125-21-210295-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1492422/000119312521210295/d198376d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-210295

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer